Abacus Global (ABX) Q3 2026 Earnings Call Transcript
Abacus Global (ABX) reported Q3 2026 earnings, highlighting strong operational and strategic progress. Key metrics include $997M in longevity fund inflows, $203.2M cash EBITDA, and a raised full-year guidance to $104.5M-$106.5M adjusted net income. The company launched the ABX Longevity Growth and Income Fund, completed a $400M securitization, and expanded LifeARC's reach through partnerships.
How this was made

The 30-second read
Why it matters
The earnings beat and raised guidance provide fresh material for traders to reassess valuation.
Market read
Strong earnings and guidance lift sentiment for ABX and its longevity niche.
What to watch
Potential regulatory scrutiny of longevity data usage could temper upside.
Background
Abacus Global presented its Q3 2026 earnings call, highlighting operational performance, new fund launches, and a large securitization.
Ticker impact
Q3 2026 earnings beat guidance and full-year outlook raised to $104.5‑$106.5M net income.
likely upward pressure as market prices in higher earnings outlook
Guidance increase of ~4% and earnings beat are fresh primary disclosures that can move the stock immediately.
Market effects
Longevity and life‑settlement segments may see increased investor interest.
U.S. market participants focused on longevity finance could adjust exposure.
Limited to investors tracking niche longevity platforms.
Counterpoint
Higher guidance may already be priced in; watch for execution risk on new securitizations.
Key entities
- companyAbacus Global
Provider of longevity‑focused financial solutions, ticker ABX.
